The Cost-Effectiveness of Frontline Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia: In Pursuit of Treatment-Free Remission and Dose Reduction.
Saved in:
| Title: | The Cost-Effectiveness of Frontline Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia: In Pursuit of Treatment-Free Remission and Dose Reduction. |
|---|---|
| Authors: | Metsemakers, Sanne J.J.P.M.1 (AUTHOR) Sanne.Metsemakers@radboudumc.nl, Hermens, Rosella P.M.G.2 (AUTHOR), Ector, Geneviève I.C.G.1 (AUTHOR), Blijlevens, Nicole M.A.1 (AUTHOR), Govers, Tim M.3,4 (AUTHOR) |
| Source: | Value in Health. Feb2025, Vol. 28 Issue 2, p224-232. 9p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
